Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
19,31 USD | -0,87% | -0,72% | -29,81% |
15/04 | VERACYTE, INC. : da Goldman Sachs è Buy | ZM |
26/02 | VERACYTE, INC. : Morgan Stanley conferma la valutazione negativa | ZM |
Attività
Numero di dipendenti: 815
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Diagnostic Products and Biopharmaceutical Services
100,0
%
| 297 | 100,0 % | 361 | 100,0 % | +21,76% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
92,7
%
| 263 | 88,7 % | 335 | 92,7 % | +27,23% |
International
7,3
%
| 34 | 11,3 % | 27 | 7,3 % | -21,08% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Marc Stapley
CEO | Chief Executive Officer | 54 | 01/06/21 |
Rebecca Chambers
DFI | Director of Finance/CFO | 46 | 19/07/21 |
Steven French
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/22 |
Phillip Febbo
CTO | Chief Tech/Sci/R&D Officer | 57 | 02/10/23 |
Richard T. Kloos
CTO | Chief Tech/Sci/R&D Officer | - | 05/04/12 |
Shayla Gorman
IRC | Investor Relations Contact | - | 01/02/22 |
Tracy Morris
IRO | Public Communications Contact | - | - |
John Leite
PRN | Corporate Officer/Principal | - | 01/09/22 |
Annie McGuire
HRO | Human Resources Officer | 44 | 28/02/22 |
Robert Brainin
PRN | Corporate Officer/Principal | 53 | 08/07/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Evan Jones
BRD | Director/Board Member | 67 | 01/02/08 |
Robert Epstein
CHM | Chairman | 69 | 12/01/15 |
Karin Eastham
BRD | Director/Board Member | 74 | 01/12/12 |
John Bishop
BRD | Director/Board Member | 79 | 01/12/14 |
Jens Holstein
BRD | Director/Board Member | 60 | 01/08/20 |
Marc Stapley
CEO | Chief Executive Officer | 54 | 01/06/21 |
Eliav Barr
BRD | Director/Board Member | - | 09/08/22 |
Muna Bhanji
BRD | Director/Board Member | 61 | 19/03/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 78 436 369 | 77 537 934 ( 98,85 %) | 0 | 98,85 % |
Coordinate società
Veracyte, Inc.
6000 Shoreline Court Suite 300
94080, South San Francisco
+650 243 6300
http://www.veracyte.comSettore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-29,81% | 1,48 Mrd | |
-20,45% | 10,82 Mrd | |
+43,17% | 3,25 Mrd | |
-35,86% | 2,11 Mrd | |
-17,21% | 2,08 Mrd | |
+17,56% | 1,02 Mrd | |
-4,37% | 733 Mln | |
-37,00% | 391 Mln | |
-46,94% | 383 Mln | |
+13,32% | 332 Mln |
- Borsa valori
- Azioni
- Azione VCYT
- Società Veracyte, Inc.